Trials / Withdrawn
WithdrawnNCT02492074
Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study
Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System and Brain Function
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Central Institute of Mental Health, Mannheim · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study evaluates the gene-environment interaction of the COMT-genotype on the effects of the phytocannabinoids delta-9-tetrahydrocannabinol, cannabidiol or a combination of both on induction of psychotic symptoms, endocannabinoid levels in human body fluids, neuronal processing, and neural oscillations. In addition the effects of the phytocannabinoids on lipid levels in serum and cerebrospinal fluid, cognition, neuronal processing assessed by fMRI as well as D2-receptor availability assessed by \[18F\] desmethoxyfallypride.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Delta-9-tetrahydrocannabinol | oral administration of delta-9-tetrahydrocannabinol |
| DRUG | Cannabidiol | oral administration of cannabidiol |
| DRUG | Placebo | oral administration of placebo |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2025-04-01
- Completion
- 2025-05-01
- First posted
- 2015-07-08
- Last updated
- 2025-03-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02492074. Inclusion in this directory is not an endorsement.